Location: New York, NY
CIK: 0001482416 · Show all filings
Period: Q3 2021 (← Previous) (Next →)
Filing Date: Nov 15, 2021
Total Value: $314M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CI | CIGNA CORP | 138,224 | $27.67M | 8.8% | $187.09 | +7.3% | COM | 125523100 |
| — | CURIS INC | 2,914,127 | $22.82M | 7.3% | $1.20 | — | COM NEW | 231269200 |
| GLD | SPDR GOLD SHARES | 102,553 | $16.84M | 5.4% | $158.61 | — | GOLD SHS | 78463V107 |
| — | SOLITON INC | 824,803 | $16.79M | 5.4% | $7.78 | — | COM | 834251100 |
| UHS | UNIVERSAL HEALTH SERVICES INC | 101,051 | $13.98M | 4.5% | $129.88 | +13.9% | CL B | 913903100 |
| HCA | HCA HEALTHCARE INC | 56,409 | $13.69M | 4.4% | $111.08 | +111.9% | COM | 40412C101 |
| GLPG | GALAPAGOS NV | 224,719 | $11.82M | 3.8% | $52.61 | — | SPON ADR | 36315X101 |
| AVAH | AVEANNA HEALTHCARE HOLDINGS INC | 1,397,272 | $11.21M | 3.6% | $11.56 | -16.2% | COM | 05356F105 |
| CNC | CENTENE CORP | 179,232 | $11.17M | 3.6% | $62.56 | +6.8% | COM | 15135B101 |
| UTHR | UNITED THERAPEUTICS CORP | 59,146 | $10.92M | 3.5% | $134.96 | +45.9% | COM | 91307C102 |
| MRK | MERCK & CO INC | 125,000 | $9.389M | 3.0% | $66.14 | 0.0% | COM | 58933Y105 |
| HLF | HERBALIFE NUTRITION LTD | 216,012 | $9.155M | 2.9% | $49.29 | +0.3% | COM SHS | G4412G101 |
| MCK | MCKESSON CORP | 43,797 | $8.732M | 2.8% | $150.14 | +29.9% | COM | 58155Q103 |
| CAH | CARDINAL HEALTH INC | 141,423 | $6.995M | 2.2% | $48.30 | +1.2% | COM | 14149Y108 |
| — | RENOVACOR INC | 736,323 | $6.664M | 2.1% | $9.05 | — | COM | 75989E106 |
| — | ALBIREO PHARMA INC | 213,493 | $6.661M | 2.1% | $33.37 | — | COM | 01345P106 |
| MIRM | MIRUM PHARMACEUTICALS INC | 248,978 | $4.96M | 1.6% | $19.59 | -17.0% | COM | 604749101 |
| ITGR | INTEGER HOLDINGS CORP | 54,891 | $4.904M | 1.6% | $92.12 | +1.6% | COM | 45826H109 |
| HQY | HEALTHEQUITY INC | 73,458 | $4.757M | 1.5% | $75.41 | -7.9% | COM | 42226A107 |
| VRTX | VERTEX PHARMACEUTICALS INC | 25,500 | $4.625M | 1.5% | $225.04 | -13.2% | COM | 92532F100 |
| GILD | GILEAD SCIENCES INC | 65,500 | $4.575M | 1.5% | $59.38 | 0.0% | COM | 375558103 |
| KURA | KURA ONCOLOGY INC | 228,318 | $4.276M | 1.4% | $30.23 | -37.7% | COM | 50127T109 |
| — | X4 PHARMACEUTICALS INC | 804,597 | $4.256M | 1.4% | $8.61 | — | COM | 98420X103 |
| CCRN | CROSS COUNTRY HEALTHCARE INC | 199,460 | $4.237M | 1.4% | $6.65 | +182.2% | COM | 227483104 |
| VKTX | VIKING THERAPEUTICS INC | 660,813 | $4.15M | 1.3% | $8.36 | -26.1% | COM | 92686J106 |
| — | SYROS PHARMACEUTICALS INC | 900,677 | $4.026M | 1.3% | $5.34 | — | COM | 87184Q107 |
| — | SPRUCE BIOSCIENCES INC | 603,027 | $3.624M | 1.2% | $22.64 | — | COM | 85209E109 |
| — | AYALA PHARMACEUTICALS INC | 318,599 | $3.613M | 1.2% | $10.72 | — | COM | 05465V108 |
| — | AEGLEA BIO THERAPEUTICS INC | 446,000 | $3.546M | 1.1% | $8.49 | — | COM | 00773J103 |
| — | RIGEL PHARMACEUTICALS INC | 913,621 | $3.316M | 1.1% | $4.27 | — | COM NEW | 766559603 |
| — | NEUBASE THERAPEUTICS INC | 906,445 | $3.272M | 1.0% | $6.16 | — | COM | 64132K102 |
| — | HORIZON THERAPEUTICS PLC | 29,319 | $3.212M | 1.0% | $78.31 | — | SHS | G46188101 |
| — | MOLECULIN BIOTECH INC | 1,040,529 | $3.122M | 1.0% | $4.03 | — | COM | 60855D200 |
| — | RADIUS HEALTH INC | 241,905 | $3.002M | 1.0% | $13.38 | — | COM NEW | 750469207 |
| — | PRECISION BIOSCIENCES INC | 257,167 | $2.968M | 0.9% | $7.40 | — | COM | 74019P108 |
| — | CATALYST BIOSCIENCES INC | 623,892 | $2.564M | 0.8% | $7.85 | — | COM NEW | 14888D208 |
| — | EUCRATES BIOMEDICAL ACQUISITION CORP. | 248,674 | $2.474M | 0.8% | $10.66 | — | UNIT 10/23/2027 | G3141W114 |
| — | HEALTH SCIENCES ACQUISITIONS CORP 2 | 250,000 | $2.473M | 0.8% | $11.00 | — | ORD SHS | G4411D109 |
| — | ASLAN PHARMACEUTICALS LTD | 1,270,758 | $2.262M | 0.7% | $1.92 | — | ADS | 04522R101 |
| — | CYCLACEL PHARMACEUTICALS INC | 422,598 | $2.227M | 0.7% | $5.91 | — | COM | 23254L603 |
| — | SIERRA ONCOLOGY INC | 95,450 | $2.092M | 0.7% | $16.79 | — | COM NEW | 82640U404 |
| — | FUSION PHARMACEUTICALS INC | 259,763 | $2.057M | 0.7% | $11.22 | — | COM | 36118A100 |
| — | CYMABAY THERAPEUTICS INC | 562,339 | $2.053M | 0.7% | $3.37 | — | COM | 23257D103 |
| QNCX | CORTEXYME INC | 22,200 | $2.035M | 0.6% | — | — | Put | 22053A107 |
| — | LEAP THERAPEUTICS INC | 440,000 | $1.764M | 0.6% | $4.01 | — | COM | 52187K101 |
| — | VINCERX PHARMA INC | 102,049 | $1.65M | 0.5% | $18.89 | — | COM NEW | 92731L106 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 90,000 | $1.595M | 0.5% | $42.63 | 0.0% | COM | 74366E102 |
| — | EVELO BIOSCIENCES INC | 206,300 | $1.452M | 0.5% | — | — | Put | 299734103 |
| — | SALARIUS PHARMACEUTICALS INC | 1,354,291 | $1.381M | 0.4% | $1.18 | — | COM NEW | 79400X107 |
| — | ARENA PHARMACEUTICALS INC | 21,738 | $1.294M | 0.4% | $47.41 | — | COM NEW | 040047607 |
| — | MEI PHARMA INC | 426,047 | $1.176M | 0.4% | $3.06 | — | COM NEW | 55279B202 |
| — | NATUS MEDICAL INC | 39,354 | $987K | 0.3% | $25.08 | — | COM | 639050103 |
| — | LOGICBIO THERAPEUTICS INC | 182,630 | $836K | 0.3% | $4.44 | — | COM | 54142F102 |
| ARDX | ARDELYX INC | 572,082 | $755K | 0.2% | $5.82 | -54.1% | COM | 039697107 |
| NYXH | NYXOAH SA | 16,310 | $477K | 0.2% | $31.50 | 0.0% | SHS | B6S7WD106 |
| — | CAREMAX INC | 30,741 | $297K | 0.1% | $10.54 | — | COM CL A | 14171W103 |
| — | NEOLEUKIN THERAPEUTICS INC | 38,312 | $277K | 0.1% | $12.32 | — | COM | 64049K104 |
| — | RENOVACOR INC | 400,000 | $274K | 0.1% | $0.69 | — | *W EXP 99/99/999 | 75989E114 |
| HUMAW | HUMACYTE INC | 49,998 | $145K | 0.0% | $2.90 | — | *W EXP 09/21/202 | 44486Q111 |
| — | RUBIUS THERAPEUTICS INC | 6,200 | $111K | 0.0% | $26.51 | — | COM | 78116T103 |
| — | CAREMAX INC | 12,808 | $36,000 | 0.0% | $2.81 | — | W EXP 06/08/2026 | 14171W111 |